Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 85 | 2024 | 9758 | 4.650 |
Why?
|
Coronary Disease | 54 | 2023 | 5914 | 3.240 |
Why?
|
Postmenopause | 27 | 2024 | 2513 | 3.020 |
Why?
|
Brain Ischemia | 25 | 2020 | 3049 | 2.540 |
Why?
|
Metabolomics | 13 | 2024 | 1659 | 2.170 |
Why?
|
Cardiovascular Diseases | 66 | 2024 | 15502 | 1.880 |
Why?
|
Women's Health | 24 | 2024 | 2065 | 1.830 |
Why?
|
Risk Factors | 168 | 2024 | 74212 | 1.380 |
Why?
|
Nurses | 22 | 2024 | 2478 | 1.300 |
Why?
|
Magnesium | 5 | 2015 | 804 | 1.250 |
Why?
|
Hypertension, Pregnancy-Induced | 7 | 2023 | 518 | 1.240 |
Why?
|
Gonadal Steroid Hormones | 7 | 2018 | 702 | 1.240 |
Why?
|
Diet | 39 | 2024 | 8075 | 1.150 |
Why?
|
Menopause | 8 | 2022 | 1646 | 1.110 |
Why?
|
Prospective Studies | 140 | 2024 | 54423 | 1.100 |
Why?
|
Potassium, Dietary | 3 | 2015 | 103 | 1.050 |
Why?
|
Estrogens | 8 | 2024 | 1522 | 1.030 |
Why?
|
Female | 285 | 2024 | 392688 | 1.010 |
Why?
|
Middle Aged | 227 | 2024 | 220917 | 1.010 |
Why?
|
Sex Hormone-Binding Globulin | 8 | 2024 | 550 | 1.000 |
Why?
|
Life Style | 26 | 2022 | 3917 | 0.990 |
Why?
|
Retinol-Binding Proteins, Plasma | 2 | 2017 | 94 | 0.980 |
Why?
|
Estrogen Replacement Therapy | 11 | 2017 | 1208 | 0.960 |
Why?
|
Menarche | 2 | 2018 | 532 | 0.960 |
Why?
|
Calcium, Dietary | 4 | 2015 | 529 | 0.960 |
Why?
|
Incidence | 66 | 2024 | 21355 | 0.880 |
Why?
|
Estrogen Receptor beta | 3 | 2009 | 168 | 0.870 |
Why?
|
Case-Control Studies | 48 | 2024 | 22176 | 0.850 |
Why?
|
Estradiol | 7 | 2024 | 1937 | 0.830 |
Why?
|
Diet, Mediterranean | 7 | 2024 | 740 | 0.820 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 56 | 0.810 |
Why?
|
Diet, Vegetarian | 2 | 2021 | 180 | 0.780 |
Why?
|
Body Mass Index | 37 | 2022 | 12953 | 0.780 |
Why?
|
Sex Characteristics | 6 | 2023 | 2639 | 0.770 |
Why?
|
Humans | 306 | 2024 | 761578 | 0.750 |
Why?
|
Dairy Products | 7 | 2021 | 490 | 0.740 |
Why?
|
Aged | 125 | 2024 | 169308 | 0.720 |
Why?
|
Hormone Replacement Therapy | 4 | 2020 | 751 | 0.710 |
Why?
|
Proportional Hazards Models | 46 | 2024 | 12463 | 0.710 |
Why?
|
Myocardial Infarction | 31 | 2023 | 11461 | 0.700 |
Why?
|
Diabetes, Gestational | 2 | 2023 | 1248 | 0.690 |
Why?
|
Intracranial Hemorrhages | 4 | 2020 | 822 | 0.680 |
Why?
|
Hypertension | 22 | 2024 | 8540 | 0.670 |
Why?
|
Disaster Medicine | 1 | 2020 | 70 | 0.670 |
Why?
|
Triglycerides | 5 | 2024 | 2461 | 0.660 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2023 | 366 | 0.660 |
Why?
|
Reproductive Health Services | 1 | 2020 | 87 | 0.660 |
Why?
|
Risk | 36 | 2020 | 9610 | 0.660 |
Why?
|
Obesity | 17 | 2023 | 12947 | 0.650 |
Why?
|
Multivariate Analysis | 34 | 2019 | 12059 | 0.650 |
Why?
|
Endometriosis | 6 | 2024 | 870 | 0.650 |
Why?
|
Phosphatidylcholines | 2 | 2018 | 405 | 0.650 |
Why?
|
C-Reactive Protein | 12 | 2018 | 3826 | 0.650 |
Why?
|
United States | 89 | 2024 | 72335 | 0.630 |
Why?
|
Pre-Eclampsia | 3 | 2023 | 1231 | 0.630 |
Why?
|
Inflammation Mediators | 5 | 2020 | 1886 | 0.620 |
Why?
|
Adult | 166 | 2024 | 221200 | 0.610 |
Why?
|
American Heart Association | 7 | 2024 | 1039 | 0.610 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2024 | 12149 | 0.610 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2024 | 1033 | 0.610 |
Why?
|
Testosterone | 6 | 2020 | 2472 | 0.600 |
Why?
|
Fatty Acids, Omega-3 | 7 | 2020 | 1390 | 0.570 |
Why?
|
Premature Birth | 4 | 2023 | 1782 | 0.550 |
Why?
|
Polymorphism, Genetic | 9 | 2009 | 4243 | 0.550 |
Why?
|
Follow-Up Studies | 62 | 2024 | 39107 | 0.540 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 329 | 0.530 |
Why?
|
Estrogen Receptor alpha | 3 | 2017 | 583 | 0.510 |
Why?
|
Longevity | 5 | 2024 | 1065 | 0.510 |
Why?
|
Menopause, Premature | 2 | 2017 | 124 | 0.490 |
Why?
|
Physicians, Primary Care | 1 | 2022 | 623 | 0.490 |
Why?
|
Inflammation | 11 | 2023 | 10774 | 0.470 |
Why?
|
Weight Gain | 5 | 2020 | 2348 | 0.450 |
Why?
|
Pregnancy | 25 | 2024 | 29876 | 0.450 |
Why?
|
Emergencies | 1 | 2020 | 1217 | 0.450 |
Why?
|
Feeding Behavior | 11 | 2021 | 3188 | 0.450 |
Why?
|
Methylamines | 4 | 2024 | 136 | 0.440 |
Why?
|
Gallstones | 3 | 2024 | 284 | 0.430 |
Why?
|
Nuts | 4 | 2020 | 264 | 0.430 |
Why?
|
Cohort Studies | 63 | 2024 | 41493 | 0.430 |
Why?
|
Dietary Fats | 9 | 2024 | 1995 | 0.420 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2013 | 241 | 0.420 |
Why?
|
Authorship | 1 | 2016 | 284 | 0.420 |
Why?
|
Myocardial Revascularization | 2 | 2016 | 790 | 0.420 |
Why?
|
Chromatography, Liquid | 4 | 2024 | 983 | 0.420 |
Why?
|
Dietary Supplements | 7 | 2020 | 3415 | 0.410 |
Why?
|
Diabetes Mellitus | 11 | 2024 | 5841 | 0.410 |
Why?
|
Vitamin D | 6 | 2020 | 3303 | 0.410 |
Why?
|
Risk Reduction Behavior | 7 | 2024 | 1112 | 0.400 |
Why?
|
Intracranial Aneurysm | 1 | 2022 | 1285 | 0.400 |
Why?
|
Cerebrovascular Disorders | 4 | 2012 | 1474 | 0.390 |
Why?
|
Odds Ratio | 16 | 2017 | 9646 | 0.380 |
Why?
|
Carotid Artery Diseases | 1 | 2018 | 877 | 0.380 |
Why?
|
Calcifediol | 1 | 2012 | 161 | 0.370 |
Why?
|
Lipids | 9 | 2023 | 3341 | 0.370 |
Why?
|
Health Status | 5 | 2019 | 4077 | 0.360 |
Why?
|
Antidepressive Agents | 3 | 2011 | 2897 | 0.360 |
Why?
|
Migraine Disorders | 3 | 2016 | 1703 | 0.350 |
Why?
|
Hormones | 3 | 2023 | 869 | 0.350 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2382 | 0.350 |
Why?
|
Longitudinal Studies | 17 | 2023 | 14607 | 0.340 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1081 | 0.340 |
Why?
|
Uric Acid | 1 | 2016 | 807 | 0.340 |
Why?
|
Sex Factors | 12 | 2022 | 10554 | 0.340 |
Why?
|
Ovulation | 2 | 2020 | 181 | 0.330 |
Why?
|
Telomere | 2 | 2014 | 943 | 0.330 |
Why?
|
Flavonoids | 1 | 2012 | 445 | 0.310 |
Why?
|
Publishing | 1 | 2016 | 833 | 0.310 |
Why?
|
Hypercholesterolemia | 6 | 2022 | 1141 | 0.310 |
Why?
|
Estrogens, Conjugated (USP) | 4 | 2020 | 276 | 0.300 |
Why?
|
Dietary Carbohydrates | 6 | 2020 | 891 | 0.300 |
Why?
|
Leukocytes | 3 | 2014 | 2026 | 0.300 |
Why?
|
Depressive Disorder | 2 | 2011 | 3728 | 0.300 |
Why?
|
Adipose Tissue | 4 | 2015 | 3313 | 0.300 |
Why?
|
Male | 96 | 2024 | 360841 | 0.300 |
Why?
|
Sleep | 4 | 2023 | 4768 | 0.300 |
Why?
|
Death, Sudden, Cardiac | 8 | 2011 | 1555 | 0.290 |
Why?
|
Risk Assessment | 27 | 2021 | 23996 | 0.290 |
Why?
|
Parity | 4 | 2021 | 927 | 0.290 |
Why?
|
Amino Acids | 3 | 2023 | 1718 | 0.280 |
Why?
|
Metabolome | 4 | 2024 | 989 | 0.280 |
Why?
|
Alcohol Drinking | 7 | 2014 | 4028 | 0.280 |
Why?
|
Child Abuse | 3 | 2023 | 1077 | 0.280 |
Why?
|
Vitamin D Deficiency | 2 | 2017 | 1388 | 0.270 |
Why?
|
Cross-Sectional Studies | 19 | 2023 | 26127 | 0.270 |
Why?
|
Genotype | 17 | 2019 | 12990 | 0.270 |
Why?
|
Aircraft | 2 | 2024 | 130 | 0.260 |
Why?
|
Dietary Fiber | 6 | 2024 | 759 | 0.260 |
Why?
|
Infertility | 2 | 2022 | 654 | 0.250 |
Why?
|
Cholesterol, HDL | 8 | 2023 | 1814 | 0.250 |
Why?
|
Electronic Health Records | 2 | 2024 | 4811 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 9 | 2018 | 17904 | 0.250 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 513 | 0.240 |
Why?
|
Tandem Mass Spectrometry | 3 | 2024 | 1188 | 0.240 |
Why?
|
Primary Prevention | 2 | 2024 | 1186 | 0.240 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1463 | 0.240 |
Why?
|
Energy Intake | 6 | 2020 | 2134 | 0.230 |
Why?
|
Biomedical Research | 2 | 2020 | 3429 | 0.230 |
Why?
|
Suicide | 1 | 2015 | 1601 | 0.230 |
Why?
|
Diabetes Complications | 4 | 2019 | 1315 | 0.230 |
Why?
|
Noise, Transportation | 1 | 2024 | 56 | 0.230 |
Why?
|
Breast Neoplasms | 12 | 2020 | 21019 | 0.230 |
Why?
|
Logistic Models | 11 | 2017 | 13255 | 0.230 |
Why?
|
Neoplasms | 10 | 2023 | 22172 | 0.230 |
Why?
|
Asphyxia | 1 | 2024 | 60 | 0.220 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2018 | 15936 | 0.220 |
Why?
|
Age Factors | 16 | 2022 | 18398 | 0.220 |
Why?
|
Premenopause | 2 | 2020 | 1039 | 0.220 |
Why?
|
Health Surveys | 9 | 2020 | 4061 | 0.220 |
Why?
|
Linear Models | 8 | 2021 | 5872 | 0.220 |
Why?
|
Aspirin | 6 | 2022 | 3133 | 0.220 |
Why?
|
Haptoglobins | 2 | 2015 | 166 | 0.210 |
Why?
|
Sterilization, Tubal | 1 | 2023 | 75 | 0.210 |
Why?
|
Adiponectin | 3 | 2018 | 1113 | 0.210 |
Why?
|
Contraceptives, Oral | 2 | 2022 | 554 | 0.210 |
Why?
|
Heart Diseases | 4 | 2021 | 2781 | 0.210 |
Why?
|
Vegetables | 5 | 2020 | 1195 | 0.210 |
Why?
|
Neck Injuries | 1 | 2024 | 160 | 0.200 |
Why?
|
Pregnancy Outcome | 3 | 2023 | 2922 | 0.200 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2023 | 137 | 0.200 |
Why?
|
Dehydroepiandrosterone | 2 | 2017 | 258 | 0.200 |
Why?
|
Environmental Exposure | 4 | 2024 | 4485 | 0.200 |
Why?
|
Abdomen | 3 | 2003 | 1128 | 0.200 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 3415 | 0.200 |
Why?
|
Choline | 1 | 2024 | 515 | 0.200 |
Why?
|
Persea | 1 | 2022 | 18 | 0.200 |
Why?
|
Acetaminophen | 3 | 2006 | 554 | 0.200 |
Why?
|
Cerebral Hemorrhage | 8 | 2017 | 2656 | 0.200 |
Why?
|
Diet, Carbohydrate-Restricted | 3 | 2023 | 262 | 0.200 |
Why?
|
Interleukin-6 | 3 | 2018 | 3208 | 0.190 |
Why?
|
Receptors, Androgen | 1 | 2008 | 1079 | 0.190 |
Why?
|
Cause of Death | 8 | 2024 | 3683 | 0.190 |
Why?
|
Fatty Acids | 3 | 2020 | 1808 | 0.190 |
Why?
|
Parabens | 1 | 2022 | 114 | 0.190 |
Why?
|
Time Factors | 21 | 2020 | 39970 | 0.190 |
Why?
|
Double-Blind Method | 7 | 2020 | 12341 | 0.190 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2018 | 344 | 0.180 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.180 |
Why?
|
Smoking | 14 | 2024 | 9053 | 0.180 |
Why?
|
Ovarian Function Tests | 1 | 2020 | 11 | 0.180 |
Why?
|
Skull Fractures | 1 | 2022 | 202 | 0.180 |
Why?
|
Genome-Wide Association Study | 9 | 2022 | 12690 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2022 | 2273 | 0.180 |
Why?
|
Facial Injuries | 1 | 2022 | 190 | 0.180 |
Why?
|
Wounds and Injuries | 3 | 2020 | 2491 | 0.180 |
Why?
|
Thromboembolism | 1 | 2007 | 995 | 0.180 |
Why?
|
Genetic Variation | 4 | 2017 | 6567 | 0.180 |
Why?
|
Haplotypes | 5 | 2009 | 2713 | 0.170 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2019 | 540 | 0.170 |
Why?
|
Herpes Zoster | 1 | 2022 | 253 | 0.170 |
Why?
|
Fats | 1 | 2020 | 99 | 0.170 |
Why?
|
Maternal Mortality | 1 | 2023 | 302 | 0.170 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2020 | 155 | 0.170 |
Why?
|
Horses | 1 | 2020 | 300 | 0.170 |
Why?
|
Men's Health | 1 | 2020 | 73 | 0.170 |
Why?
|
Leiomyoma | 1 | 2024 | 636 | 0.170 |
Why?
|
Exercise | 11 | 2020 | 5890 | 0.170 |
Why?
|
Stress, Psychological | 3 | 2024 | 4481 | 0.170 |
Why?
|
Socioeconomic Factors | 6 | 2020 | 7827 | 0.170 |
Why?
|
Time | 2 | 2020 | 546 | 0.160 |
Why?
|
Food Preferences | 2 | 2020 | 398 | 0.160 |
Why?
|
Fractures, Bone | 2 | 2021 | 2046 | 0.160 |
Why?
|
Depression | 5 | 2020 | 8124 | 0.160 |
Why?
|
Sex Offenses | 1 | 2023 | 352 | 0.160 |
Why?
|
Air Pollution | 3 | 2020 | 2359 | 0.160 |
Why?
|
Lipid Metabolism | 4 | 2024 | 1902 | 0.160 |
Why?
|
Nutrition Assessment | 2 | 2019 | 728 | 0.160 |
Why?
|
Overweight | 2 | 2011 | 2417 | 0.150 |
Why?
|
Milk | 1 | 2021 | 443 | 0.150 |
Why?
|
Forecasting | 2 | 2017 | 2928 | 0.150 |
Why?
|
Gene Frequency | 4 | 2009 | 3606 | 0.150 |
Why?
|
Birth Weight | 2 | 2023 | 2103 | 0.150 |
Why?
|
Phenols | 1 | 2022 | 517 | 0.150 |
Why?
|
Placebos | 2 | 2020 | 1667 | 0.150 |
Why?
|
Genetic Loci | 5 | 2019 | 2632 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2001 | 370 | 0.150 |
Why?
|
Work Schedule Tolerance | 2 | 2015 | 551 | 0.150 |
Why?
|
Infertility, Female | 1 | 2024 | 760 | 0.150 |
Why?
|
Sex Distribution | 5 | 2017 | 2280 | 0.150 |
Why?
|
Mortality | 4 | 2021 | 2901 | 0.150 |
Why?
|
Waist-Hip Ratio | 3 | 2015 | 518 | 0.150 |
Why?
|
Kentucky | 1 | 2017 | 84 | 0.150 |
Why?
|
Blood Pressure | 5 | 2019 | 8481 | 0.140 |
Why?
|
Hyperinsulinism | 1 | 2020 | 400 | 0.140 |
Why?
|
Vitamin E | 2 | 2012 | 872 | 0.140 |
Why?
|
Aged, 80 and over | 21 | 2023 | 58983 | 0.140 |
Why?
|
Nutrition Policy | 1 | 2021 | 471 | 0.140 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1303 | 0.140 |
Why?
|
Gravidity | 1 | 2017 | 50 | 0.140 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 256 | 0.140 |
Why?
|
Fruit | 4 | 2016 | 1160 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2015 | 10766 | 0.140 |
Why?
|
Cholesterol | 3 | 2022 | 2905 | 0.140 |
Why?
|
Nutritive Value | 1 | 2020 | 350 | 0.140 |
Why?
|
Survivors | 3 | 2017 | 2371 | 0.140 |
Why?
|
Prehypertension | 1 | 2017 | 63 | 0.140 |
Why?
|
Erythrocytes | 4 | 2020 | 2413 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
Intracranial Thrombosis | 1 | 2017 | 108 | 0.130 |
Why?
|
Vitamin D-Binding Protein | 1 | 2017 | 131 | 0.130 |
Why?
|
Purines | 1 | 2020 | 607 | 0.130 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6403 | 0.130 |
Why?
|
Leukoencephalopathies | 1 | 2019 | 256 | 0.130 |
Why?
|
Dyslipidemias | 2 | 2021 | 868 | 0.130 |
Why?
|
Predictive Value of Tests | 9 | 2024 | 15266 | 0.130 |
Why?
|
Prognosis | 10 | 2020 | 29629 | 0.130 |
Why?
|
Intracranial Embolism | 1 | 2017 | 189 | 0.130 |
Why?
|
Workload | 1 | 2022 | 844 | 0.130 |
Why?
|
Sodium Chloride, Dietary | 2 | 2009 | 293 | 0.130 |
Why?
|
Food | 1 | 2020 | 774 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2001 | 809 | 0.130 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2017 | 343 | 0.120 |
Why?
|
Specialization | 1 | 2020 | 778 | 0.120 |
Why?
|
Blood Pressure Determination | 2 | 2017 | 633 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 916 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 2 | 2017 | 789 | 0.120 |
Why?
|
Glutamine | 1 | 2018 | 577 | 0.120 |
Why?
|
Diet Surveys | 6 | 2021 | 1162 | 0.120 |
Why?
|
Seafood | 3 | 2003 | 393 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 579 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2016 | 1126 | 0.120 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2015 | 224 | 0.110 |
Why?
|
Physicians, Women | 1 | 2020 | 509 | 0.110 |
Why?
|
Cyclohexanols | 1 | 2014 | 126 | 0.110 |
Why?
|
Climate Change | 1 | 2020 | 501 | 0.110 |
Why?
|
Parenting | 1 | 2020 | 701 | 0.110 |
Why?
|
Rural Health | 1 | 2015 | 296 | 0.110 |
Why?
|
Abdominal Fat | 3 | 2015 | 221 | 0.110 |
Why?
|
Dietary Proteins | 3 | 2011 | 952 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1088 | 0.110 |
Why?
|
Drug Utilization | 1 | 2019 | 1188 | 0.110 |
Why?
|
Trace Elements | 1 | 2015 | 195 | 0.110 |
Why?
|
Obstetrics | 1 | 2020 | 665 | 0.110 |
Why?
|
Carbonated Beverages | 2 | 2012 | 210 | 0.110 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 203 | 0.110 |
Why?
|
Republic of Korea | 1 | 2015 | 590 | 0.110 |
Why?
|
Progesterone | 1 | 2017 | 742 | 0.110 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 5127 | 0.110 |
Why?
|
Fasting | 2 | 2017 | 1603 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2020 | 834 | 0.110 |
Why?
|
Coffee | 2 | 2009 | 593 | 0.110 |
Why?
|
Diabetic Angiopathies | 3 | 2009 | 803 | 0.110 |
Why?
|
Urban Health | 1 | 2015 | 532 | 0.110 |
Why?
|
Nutritional Status | 1 | 2021 | 1615 | 0.100 |
Why?
|
Inhalation Exposure | 1 | 2015 | 432 | 0.100 |
Why?
|
ROC Curve | 2 | 2018 | 3578 | 0.100 |
Why?
|
Fibrinogen | 1 | 2016 | 888 | 0.100 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 532 | 0.100 |
Why?
|
Lactation | 2 | 2020 | 397 | 0.100 |
Why?
|
Kidney | 3 | 2004 | 7048 | 0.100 |
Why?
|
Comorbidity | 6 | 2022 | 10508 | 0.100 |
Why?
|
Hyperglycemia | 2 | 2020 | 1376 | 0.100 |
Why?
|
Databases, Nucleic Acid | 1 | 2013 | 205 | 0.100 |
Why?
|
Anthropometry | 3 | 2003 | 1349 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 983 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3415 | 0.100 |
Why?
|
Breast | 2 | 2012 | 1967 | 0.100 |
Why?
|
United States Department of Agriculture | 1 | 2012 | 47 | 0.100 |
Why?
|
Glutamic Acid | 1 | 2018 | 1176 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2024 | 80646 | 0.100 |
Why?
|
Aromatase | 1 | 2012 | 147 | 0.100 |
Why?
|
Citrus | 1 | 2012 | 49 | 0.100 |
Why?
|
Medicine | 1 | 2020 | 942 | 0.100 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3801 | 0.100 |
Why?
|
Constipation | 1 | 2016 | 563 | 0.100 |
Why?
|
Health Status Indicators | 2 | 2014 | 970 | 0.100 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.090 |
Why?
|
Alleles | 4 | 2012 | 6864 | 0.090 |
Why?
|
Activities of Daily Living | 1 | 2020 | 2421 | 0.090 |
Why?
|
Bereavement | 1 | 2015 | 308 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1117 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3600 | 0.090 |
Why?
|
Particulate Matter | 2 | 2020 | 2605 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7406 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8002 | 0.090 |
Why?
|
Androgens | 2 | 2009 | 1286 | 0.090 |
Why?
|
Life Expectancy | 1 | 2018 | 1242 | 0.090 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 271 | 0.090 |
Why?
|
Dietary Sucrose | 2 | 2012 | 243 | 0.090 |
Why?
|
Aging | 3 | 2018 | 8711 | 0.090 |
Why?
|
Anti-Mullerian Hormone | 2 | 2024 | 407 | 0.090 |
Why?
|
Parathyroid Hormone | 1 | 2017 | 1803 | 0.090 |
Why?
|
Motor Activity | 4 | 2011 | 2715 | 0.090 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2011 | 127 | 0.090 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2014 | 277 | 0.090 |
Why?
|
Reference Values | 3 | 2017 | 4920 | 0.090 |
Why?
|
Smoking Cessation | 2 | 2020 | 2057 | 0.090 |
Why?
|
Meat | 3 | 2011 | 584 | 0.090 |
Why?
|
Young Adult | 12 | 2024 | 59254 | 0.090 |
Why?
|
Reference Standards | 1 | 2013 | 1003 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1242 | 0.090 |
Why?
|
Preventive Health Services | 1 | 2014 | 567 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2358 | 0.080 |
Why?
|
Diarrhea | 1 | 2016 | 1318 | 0.080 |
Why?
|
Child Abuse, Sexual | 1 | 2012 | 403 | 0.080 |
Why?
|
Sunlight | 1 | 2011 | 337 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Adolescent | 13 | 2024 | 88323 | 0.080 |
Why?
|
Hydrocortisone | 1 | 2017 | 1819 | 0.080 |
Why?
|
Iron | 2 | 2008 | 1793 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3113 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1200 | 0.080 |
Why?
|
Quality Improvement | 1 | 2024 | 3801 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1635 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4399 | 0.080 |
Why?
|
Hysterectomy | 2 | 2024 | 857 | 0.080 |
Why?
|
Health Behavior | 4 | 2019 | 2644 | 0.080 |
Why?
|
Vehicle Emissions | 1 | 2013 | 656 | 0.080 |
Why?
|
Drinking Behavior | 1 | 2009 | 103 | 0.080 |
Why?
|
Antioxidants | 1 | 1996 | 1668 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2015 | 2095 | 0.080 |
Why?
|
Glycemic Index | 2 | 2008 | 396 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2014 | 1475 | 0.080 |
Why?
|
Pyrimidines | 1 | 2020 | 3028 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2016 | 4575 | 0.070 |
Why?
|
Pregnancy Proteins | 1 | 2008 | 222 | 0.070 |
Why?
|
Infant, Newborn | 7 | 2023 | 26198 | 0.070 |
Why?
|
Massachusetts | 4 | 2023 | 8830 | 0.070 |
Why?
|
Galectin 2 | 1 | 2007 | 13 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1386 | 0.070 |
Why?
|
Lymphotoxin-alpha | 1 | 2007 | 93 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3624 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2007 | 150 | 0.070 |
Why?
|
Complement Factor H | 1 | 2007 | 110 | 0.070 |
Why?
|
Cholecalciferol | 1 | 2012 | 553 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.070 |
Why?
|
Physical Fitness | 2 | 2001 | 743 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2009 | 488 | 0.070 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2011 | 1725 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36426 | 0.070 |
Why?
|
Societies, Medical | 2 | 2020 | 3905 | 0.070 |
Why?
|
Animals | 9 | 2023 | 168475 | 0.070 |
Why?
|
Body Composition | 1 | 2015 | 2426 | 0.070 |
Why?
|
Population Surveillance | 1 | 2016 | 2598 | 0.070 |
Why?
|
PPAR gamma | 2 | 2007 | 484 | 0.060 |
Why?
|
Down-Regulation | 1 | 2013 | 2919 | 0.060 |
Why?
|
Trans Fatty Acids | 1 | 2007 | 155 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2008 | 784 | 0.060 |
Why?
|
Calcium | 2 | 2014 | 5722 | 0.060 |
Why?
|
Glucose | 2 | 2008 | 4347 | 0.060 |
Why?
|
Epidemiologic Methods | 3 | 2019 | 1336 | 0.060 |
Why?
|
Waist Circumference | 1 | 2009 | 935 | 0.060 |
Why?
|
C-Peptide | 2 | 2020 | 440 | 0.060 |
Why?
|
Mammography | 3 | 2014 | 2430 | 0.060 |
Why?
|
Primary Health Care | 1 | 2022 | 4686 | 0.060 |
Why?
|
Estriol | 1 | 2024 | 53 | 0.060 |
Why?
|
Progestins | 1 | 2007 | 301 | 0.060 |
Why?
|
Vitamin K 1 | 1 | 2005 | 47 | 0.060 |
Why?
|
Prevalence | 8 | 2018 | 15732 | 0.060 |
Why?
|
Heme | 1 | 2007 | 313 | 0.060 |
Why?
|
Creatinine | 4 | 2004 | 1899 | 0.060 |
Why?
|
Family | 1 | 2015 | 3194 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7879 | 0.060 |
Why?
|
Coronary Artery Bypass | 2 | 2011 | 2188 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2020 | 10212 | 0.060 |
Why?
|
Probability | 4 | 2018 | 2477 | 0.060 |
Why?
|
Colorectal Neoplasms | 3 | 2012 | 6938 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 950 | 0.060 |
Why?
|
Beverages | 1 | 2009 | 821 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 486 | 0.050 |
Why?
|
Physical Exertion | 1 | 2006 | 667 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6391 | 0.050 |
Why?
|
Nucleosides | 1 | 2023 | 131 | 0.050 |
Why?
|
Linkage Disequilibrium | 3 | 2018 | 1998 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5440 | 0.050 |
Why?
|
Circadian Rhythm | 2 | 2017 | 2576 | 0.050 |
Why?
|
Body Height | 1 | 2009 | 1570 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15843 | 0.050 |
Why?
|
DNA | 3 | 2023 | 7213 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2005 | 439 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 652 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1410 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5336 | 0.050 |
Why?
|
Airports | 1 | 2021 | 29 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3205 | 0.050 |
Why?
|
China | 2 | 2017 | 2374 | 0.050 |
Why?
|
Lactase | 1 | 2021 | 71 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3093 | 0.050 |
Why?
|
Carcinoma | 1 | 2012 | 2330 | 0.050 |
Why?
|
Ovarian Follicle | 1 | 2022 | 244 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2720 | 0.050 |
Why?
|
Patient Compliance | 1 | 2011 | 2690 | 0.050 |
Why?
|
Ovariectomy | 1 | 2023 | 614 | 0.050 |
Why?
|
Kynurenine | 1 | 2021 | 141 | 0.040 |
Why?
|
Folic Acid | 2 | 2005 | 1323 | 0.040 |
Why?
|
Carnitine | 1 | 2021 | 252 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2022 | 726 | 0.040 |
Why?
|
Breast Feeding | 1 | 2008 | 1360 | 0.040 |
Why?
|
Self Report | 3 | 2020 | 3725 | 0.040 |
Why?
|
Quality of Life | 1 | 2002 | 13367 | 0.040 |
Why?
|
Analgesics | 2 | 2006 | 1070 | 0.040 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2024 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20099 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5882 | 0.040 |
Why?
|
Corneal Diseases | 1 | 2005 | 542 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4111 | 0.040 |
Why?
|
Insulin Resistance | 2 | 2015 | 3964 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5779 | 0.040 |
Why?
|
Regression Analysis | 3 | 2008 | 6344 | 0.040 |
Why?
|
Fertility | 1 | 2024 | 771 | 0.040 |
Why?
|
Tryptophan | 1 | 2021 | 482 | 0.040 |
Why?
|
Child Care | 1 | 2020 | 124 | 0.040 |
Why?
|
Parental Leave | 1 | 2020 | 93 | 0.040 |
Why?
|
Bayes Theorem | 2 | 2019 | 2330 | 0.040 |
Why?
|
Mothers | 2 | 2020 | 2198 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2022 | 539 | 0.040 |
Why?
|
Diet Records | 2 | 2014 | 427 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 299 | 0.040 |
Why?
|
Fabaceae | 2 | 2011 | 103 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6992 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 469 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 266 | 0.030 |
Why?
|
Mass Screening | 2 | 2024 | 5428 | 0.030 |
Why?
|
Child | 7 | 2023 | 80157 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2020 | 1045 | 0.030 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2017 | 138 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5790 | 0.030 |
Why?
|
Awards and Prizes | 1 | 2020 | 360 | 0.030 |
Why?
|
Upper Extremity | 1 | 2021 | 658 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2024 | 1420 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10721 | 0.030 |
Why?
|
Fishes | 2 | 2011 | 603 | 0.030 |
Why?
|
Potassium | 1 | 1999 | 1311 | 0.030 |
Why?
|
Up-Regulation | 2 | 2015 | 4125 | 0.030 |
Why?
|
Genetic Testing | 1 | 2008 | 3537 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1567 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 552 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.030 |
Why?
|
Career Choice | 1 | 2020 | 756 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2011 | 2927 | 0.030 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2014 | 190 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81539 | 0.030 |
Why?
|
Politics | 1 | 2020 | 815 | 0.030 |
Why?
|
Survival Rate | 3 | 2016 | 12725 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 701 | 0.030 |
Why?
|
Insulin | 2 | 2021 | 6597 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 675 | 0.030 |
Why?
|
Saliva | 1 | 2017 | 828 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2091 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1380 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3420 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 1996 | 575 | 0.030 |
Why?
|
Paternal Age | 1 | 2012 | 87 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 369 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7859 | 0.020 |
Why?
|
Food Handling | 1 | 2011 | 154 | 0.020 |
Why?
|
Eating | 2 | 2011 | 1539 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4761 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1742 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8633 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1385 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2014 | 1596 | 0.020 |
Why?
|
Eggs | 1 | 2011 | 182 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 478 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.020 |
Why?
|
Chemoprevention | 1 | 2012 | 326 | 0.020 |
Why?
|
Wakefulness | 1 | 2017 | 1265 | 0.020 |
Why?
|
Bacteria | 1 | 2021 | 2199 | 0.020 |
Why?
|
Health Occupations | 1 | 2011 | 222 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2015 | 1007 | 0.020 |
Why?
|
Glycosylation | 1 | 2013 | 1097 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3563 | 0.020 |
Why?
|
Sweetening Agents | 1 | 2012 | 290 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1745 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4615 | 0.020 |
Why?
|
Molecular Weight | 1 | 2011 | 2186 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 732 | 0.020 |
Why?
|
Age Distribution | 2 | 2007 | 2879 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42231 | 0.020 |
Why?
|
Iron, Dietary | 1 | 2008 | 148 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2373 | 0.020 |
Why?
|
Walking | 2 | 2008 | 1198 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3530 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1999 | 2751 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 291 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10090 | 0.020 |
Why?
|
Iron Overload | 1 | 2008 | 239 | 0.020 |
Why?
|
Urinalysis | 1 | 2009 | 368 | 0.020 |
Why?
|
Body Weight | 1 | 1997 | 4618 | 0.020 |
Why?
|
Morbidity | 1 | 2011 | 1751 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3889 | 0.020 |
Why?
|
Cattle | 1 | 2011 | 3849 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3517 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 992 | 0.020 |
Why?
|
Ferritins | 1 | 2008 | 598 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3335 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2008 | 1178 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3306 | 0.020 |
Why?
|
Chromium Compounds | 1 | 2004 | 7 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2003 | 2178 | 0.010 |
Why?
|
Plasma | 1 | 2008 | 586 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2006 | 641 | 0.010 |
Why?
|
Fish Oils | 1 | 2008 | 483 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2013 | 2135 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 2008 | 561 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2015 | 3096 | 0.010 |
Why?
|
Models, Statistical | 1 | 2018 | 5079 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 321 | 0.010 |
Why?
|
Ethanol | 1 | 2010 | 1324 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2007 | 1574 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9319 | 0.010 |
Why?
|
Edetic Acid | 1 | 2003 | 276 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 605 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1776 | 0.010 |
Why?
|
Melanoma | 1 | 2000 | 5709 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2004 | 585 | 0.010 |
Why?
|
Swine | 1 | 2011 | 5915 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3461 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9281 | 0.010 |
Why?
|
Chlorides | 1 | 2004 | 665 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2008 | 907 | 0.010 |
Why?
|
Caffeine | 1 | 2006 | 700 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 2003 | 679 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1601 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2014 | 64684 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2001 | 224 | 0.010 |
Why?
|
Sunscreening Agents | 1 | 2000 | 139 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14665 | 0.010 |
Why?
|
Administration, Oral | 1 | 2006 | 4021 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8224 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6228 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6484 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1648 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36193 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 6180 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2005 | 1733 | 0.010 |
Why?
|
Syndrome | 1 | 2003 | 3267 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16592 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20569 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1257 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2000 | 1080 | 0.010 |
Why?
|
Boston | 1 | 2008 | 9326 | 0.010 |
Why?
|
Medical Records | 1 | 2001 | 1408 | 0.010 |
Why?
|
Physicians | 2 | 2003 | 4591 | 0.010 |
Why?
|
Health Education | 1 | 2000 | 1052 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2003 | 2244 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 2472 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2001 | 2882 | 0.010 |
Why?
|
Heart Failure | 1 | 2013 | 11671 | 0.010 |
Why?
|